These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37276913)

  • 61. Efficacy and Tolerability of Telmisartan/Amlodipine + Hydrochlorothiazide Versus Telmisartan/Amlodipine Combination Therapy for Essential Hypertension Uncontrolled With Telmisartan/Amlodipine: The Phase III, Multicenter, Randomized, Double-blind TAHYTI Study.
    Sung KC; Oh YS; Cha DH; Hong SJ; Won KH; Yoo KD; Rha SW; Ahn YK; Ahn JC; Jang JY; Hong TJ; Cho SK; Park SH; Hyon MS; Nam CW; Chae IH; Yoo BS; Song JM; Jeong JO; Yoon YW; Kim BS; Yang TH; Cho DK; Kim SH; Choi YJ; Ahn JH; Jeon DW; Kim HS
    Clin Ther; 2018 Jan; 40(1):50-63.e3. PubMed ID: 29248384
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Irbesartan reduces QT dispersion in hypertensive individuals.
    Lim PO; Nys M; Naas AA; Struthers AD; Osbakken M; MacDonald TM
    Hypertension; 1999 Feb; 33(2):713-8. PubMed ID: 10024334
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Combination Therapy in Patients with Hypertension Not Controlled with Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy: Results of a Randomized, Double-Blind, Multicenter Trial.
    Sohn IS; Kim CJ; Oh BH; Hong TJ; Park CG; Kim BS; Chung WB;
    Am J Cardiovasc Drugs; 2016 Apr; 16(2):129-38. PubMed ID: 26691333
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of antihypertensive drugs on central blood pressure in humans: a preliminary observation.
    Agnoletti D; Zhang Y; Borghi C; Blacher J; Safar ME
    Am J Hypertens; 2013 Aug; 26(8):1045-52. PubMed ID: 23736112
    [TBL] [Abstract][Full Text] [Related]  

  • 65. An elective-titration study of the comparative effectiveness of two angiotensin II-receptor blockers, irbesartan and losartan. Irbesartan/Losartan Study Investigators.
    Oparil S; Guthrie R; Lewin AJ; Marbury T; Reilly K; Triscari J; Witcher JA
    Clin Ther; 1998; 20(3):398-409. PubMed ID: 9663357
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Efficacy and safety of irbesartan/HCTZ combination therapy as initial treatment for rapid control of severe hypertension.
    Neutel JM; Franklin SS; Oparil S; Bhaumik A; Ptaszynska A; Lapuerta P
    J Clin Hypertens (Greenwich); 2006 Dec; 8(12):850-7; quiz 858-9. PubMed ID: 17170610
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Fixed Low-Dose Triple Combination Antihypertensive Medication vs Usual Care for Blood Pressure Control in Patients With Mild to Moderate Hypertension in Sri Lanka: A Randomized Clinical Trial.
    Webster R; Salam A; de Silva HA; Selak V; Stepien S; Rajapakse S; Amarasekara S; Amarasena N; Billot L; de Silva AP; Fernando M; Guggilla R; Jan S; Jayawardena J; Maulik PK; Mendis S; Mendis S; Munasinghe J; Naik N; Prabhakaran D; Ranasinghe G; Thom S; Tisserra N; Senaratne V; Wijekoon S; Wijeyasingam S; Rodgers A; Patel A;
    JAMA; 2018 Aug; 320(6):566-579. PubMed ID: 30120478
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Olmesartan medoxomil plus amlodipine increases efficacy in patients with moderate-to-severe hypertension after monotherapy: a randomized, double-blind, parallel-group, multicentre study.
    Barrios V; Brommer P; Haag U; Calderón A; Escobar C
    Clin Drug Investig; 2009; 29(7):427-439. PubMed ID: 19499960
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Efficacy and safety of the single pill combination of valsartan 80 mg plus amlodipine 5 mg in mild to moderate essential hypertensive patients without adequate blood pressure control by monotherapy].
    Ke YN; Huang J; Zhu JR;
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Sep; 37(9):794-9. PubMed ID: 20128376
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Long-term tolerability and efficacy of the combination of amlodipine/valsartan in hypertensive patients: a 54-week, open-label extension study.
    Philipp T; Glazer RD; Zhao Y; Pospiech R
    Curr Med Res Opin; 2009 Jan; 25(1):187-93. PubMed ID: 19210151
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A comparison of the efficacy and safety of irbesartan/HCTZ combination therapy with irbesartan and HCTZ monotherapy in the treatment of moderate hypertension.
    Neutel JM; Franklin SS; Lapuerta P; Bhaumik A; Ptaszynska A
    J Hum Hypertens; 2008 Apr; 22(4):266-74. PubMed ID: 17928878
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A home blood pressure monitoring study comparing the antihypertensive efficacy of two angiotensin II receptor antagonist fixed combinations.
    Bobrie G; Delonca J; Moulin C; Giacomino A; Postel-Vinay N; Asmar R;
    Am J Hypertens; 2005 Nov; 18(11):1482-8. PubMed ID: 16280286
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Randomized, double-blind, crossover comparison of amlodipine and valsartan in african-americans with hypertension using 24-hour ambulatory blood pressure monitoring.
    Maciejewski S; Mohiuddin SM; Packard KA; Mooss AN; Reyes AP; Aryana A; Hilleman DE
    Pharmacotherapy; 2006 Jul; 26(7):889-95. PubMed ID: 16803420
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Long-term safety and antihypertensive efficacy of irbesartan: pooled results of five open-label studies.
    Littlejohn T; Saini R; Kassler-Taub K; Chrysant SG; Marbury T
    Clin Exp Hypertens; 1999 Nov; 21(8):1273-95. PubMed ID: 10574413
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Randomized study to compare valsartan +/- HCTZ versus amlodipine +/- HCTZ strategies to maximize blood pressure control.
    Zappe D; Papst CC; Ferber P;
    Vasc Health Risk Manag; 2009; 5():883-92. PubMed ID: 19898644
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Blood pressure-lowering efficacy of indapamide SR/amlodipine combination in older patients with hypertension: A post hoc analysis of the NESTOR trial (Natrilix SR vs Enalapril in Hypertensive Type 2 Diabetics With Microalbuminuria).
    Hanon O; Caillard L; Chaussade E; Hernandorena I; Boully C
    J Clin Hypertens (Greenwich); 2017 Oct; 19(10):965-972. PubMed ID: 28721700
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The long-term antihypertensive activity and tolerability of irbesartan with hydrochlorothiazide.
    Raskin P; Guthrie R; Flack J; Reeves R; Saini R
    J Hum Hypertens; 1999 Oct; 13(10):683-7. PubMed ID: 10516738
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The effects of amlodipine compared to losartan in patients with mild to moderately severe hypertension.
    Phillips RA; Kloner RA; Grimm RH; Weinberger M
    J Clin Hypertens (Greenwich); 2003; 5(1):17-23. PubMed ID: 12556649
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The role of ambulatory blood pressure monitoring compared with clinic and home blood pressure measures in evaluating moderate versus intensive treatment of hypertension with amlodipine/valsartan for patients uncontrolled on angiotensin receptor blocker monotherapy.
    Giles TD; Oparil S; Ofili EO; Pitt B; Purkayastha D; Hilkert R; Samuel R; Sowers JR
    Blood Press Monit; 2011 Apr; 16(2):87-95. PubMed ID: 21386706
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Blood pressure effects of high-dose amlodipine-benazepril combination in Black and White hypertensive patients not controlled on monotherapy.
    Chrysant SG
    Drugs R D; 2012 Jun; 12(2):57-64. PubMed ID: 22571394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.